...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism
【24h】

Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism

机译:骨质量,通过小梁骨评分对患有或不患有亚临床皮质醇过多症的肾上腺偶发瘤患者进行测量

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Patients with adrenal incidentalomas (AIs) and subclinical hypercortisolism (SH) have increased risk of fracture independent of bone mineral density (BMD) and possibly due to reduced bone quality. The trabecular bone score (TBS) has been proposed as a index of bone microarchitecture. The aim of the study was to investigate TBS in AI. In 102 AI patients, SH was diagnosed in the presence of at least two of the following: (1) urinary free cortisol >70 μg/24 h (193.1 nmol/L); (2) cortisol after 1-mg dexamethasone suppression test (1-mg DST) >3.0 μg/dL (82.8 nmol/L); or (3) adrenocorticotropic hormone (ACTH) <10 pg/mL (<2.2 pmol/L). In patients and in 70 matched controls, BMD was measured at lumbar spine (LS) and femur (neck [FN] and total [FT]) by dual X-ray absorptiometry and TBS was assessed in the region of LS-BMD; BMD and TBS data were reported as Z-scores. In patients, vertebral deformities were assessed by radiograph. Patients with SH (n = 34) had lower LS-BMD (-0.31 ± 1.17), FT-BMD (-0.29 ± 0.91), and TBS (-3.18 ± 1.21) than patients without SH (n = 68, 0.31 ± 1.42, p = 0.03; 0.19 ± 0.97, p = 0.01; -1.70 ± 1.54, p < 0.0001, respectively) and controls (0.42 ± 1.52, p = 0.02; 0.14 ± 0.76, p = 0.02; -1.19 ± 0.99, p < 0.0001, respectively). TBS was inversely correlated with 1-mg DST (β = -0.26, t = -2.79, p = 0.006) regardless of age, LS-BMD, body mass index (BMI), and gender. The presence of fracture was associated with low TBS alone (odds ratio [OR], 4.8; 95% confidence interval [CI], 1.85-12.42, p = 0.001) and with the cluster low TBS plus low LS-BMD (OR, 4.37; 95% CI, 1.71-11.4, p = 0.002), after adjustment for age, BMI, and gender. Low TBS plus low LS-BMD showed a good specificity (79%) for predicting fractures, whereas normal TBS (ie, > -1.5) plus normal LS-BMD high specificity (88.1%) for excluding fractures. Finally, TBS predicted the occurrence of a new fracture in 40 patients followed for 24 months (OR, 11.2; 95%CI, 1.71-71.41, p = 0.012) regardless of LS-BMD, BMI, and age. In SH, bone quality, as measured by TBS, is altered. TBS is useful in detecting AI patients at risk of fractures.
机译:患有肾上腺偶发瘤(AIs)和亚临床皮质醇过多症(SH)的患者发生骨折的风险增加,而与骨矿物质密度(BMD)无关,并且可能是由于骨质量下降所致。小梁骨评分(TBS)已被提议作为骨微结构的指标。该研究的目的是研究AI中的TBS。在102名AI患者中,SH被诊断为存在以下至少两种:(1)尿游离皮质醇> 70μg/ 24 h(193.1 nmol / L); (2)1 mg地塞米松抑制试验(1-mg DST)> 3.0μg/ dL(82.8 nmol / L)后的皮质醇;或(3)促肾上腺皮质激素(ACTH)<10 pg / mL(<2.2 pmol / L)。在患者和70位相匹配的对照组中,通过双X线吸收法测量腰椎(LS)和股骨(颈部[FN]和总[FT])的BMD,并在LS-BMD区域评估TBS。 BMD和TBS数据报告为Z评分。在患者中,通过射线照相评估椎骨畸形。 SH患者(n = 34)的LS-BMD(-0.31±1.17),FT-BMD(-0.29±0.91)和TBS(-3.18±1.21)低于无SH患者(n = 68,0.31±1.42) ,p = 0.03; 0.19±0.97,p = 0.01; -1.70±1.54,p <0.0001)和对照(0.42±1.52,p = 0.02; 0.14±0.76,p = 0.02; -1.19±0.99,p <分别为0.0001)。无论年龄,LS-BMD,体重指数(BMI)和性别如何,TBS与1-mg DST呈负相关(β= -0.26,t = -2.79,p = 0.006)。骨折的存在与低TBS单独相关(优势比[OR],4.8; 95%置信区间[CI],1.85-12.42,p = 0.001)以及集群性低TBS和低LS-BMD(OR,4.37) ; 95%CI,1.71-11.4,p = 0.002)(针对年龄,BMI和性别进行调整后)。低TBS加低LS-BMD对预测骨折表现出良好的特异性(79%),而正常TBS(即> -1.5)加正常LS-BMD对骨折的排除率很高(88.1%)。最后,TBS预测40名患者的新骨折发生情况,随访24个月(OR,11.2; 95%CI,1.71-71.41,p = 0.012),而与LS-BMD,BMI和年龄无关。在SH中,通过TBS测量的骨骼质量发生了变化。 TBS可用于检测有骨折风险的AI患者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号